|
[1]Jemal A, Bray F, Center MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90.
|
|
[2]Liu L, Zhu XD, Wang WQ, et al.Activation of beta-cateninby hypoxia in hepatocellular carcinoma contributes to en-hanced metastatic potential and poor prognosis[J].ClinCancer Res, 2010, 16 (10) :2740-2750.
|
|
[3]Huang XY, Huang ZL, Wang L, et al.Herbal compound"Songyou Yin"reinforced the ability of interferon-alfa to in-hibit the enhanced metastatic potential induced by palliativeresection of hepatocellular carcinoma in nude mice[J].BMCCancer, 2010, 10:580.
|
|
[4]Ellis LM, Reardon DA.Is there really a yin and yang to VEGF-targeted therapies[J].Lancet Oncol, 2010, 11 (9) :809-811.
|
|
[5]Ye QH, Qin LX, Forgues M, et al.Predicting hepatitis B vi-rus-positive metastatic hepatocellular carcinomas usinggene expression profiling and supervised machine learning[J].Nat Med, 2003, 9 (4) :416-423.
|
|
[6]Shen YC, Hsu C, Chen LT, et al.Adjuvant interferon therapyafter curative therapy for hepatocellular carcinoma (HCC) :ameta-regression approach[J].J Hepatol, 2010, 52 (6) :889-894.
|
|
[7]Zhang XW, Yan XJ, Zhou ZR, et al.Arsenic trioxide controlsthe fate of the PML-RARalpha oncoprotein by directly bind-ing PML[J].Science, 2010, 328 (5975) :240-243.
|
|
[8]Grivennikov SI, Greten FR, Karin M.Immunity, inflamma-tion, and cancer[J].Cell, 2010, 140 (6) :883-899.
|
|
[9]Dinarello CA.Anti-inflammatory agents:present and future[J].Cell, 2010, 140 (6) :935-950.
|
|
[10]Jacobs EJ.Will an aspirin a day help keep fatal cancer away?[J].Lancet, 2011, 377 (9759) :3-4.
|
|
[11]Zhang W, Zhu XD, Sun HC, et al.Depletion of tumor-associ-ated macrophages enhances the effect of sorafenib in metastat-ic liver cancer models by antimetastatic and antiangiogeniceffects[J].Clin Cancer Res, 2010, 16 (13) :3420-3430.
|
|
[12]Hart GW, Copeland RJ.Glycomics hits the big time[J].Cell, 2010, 143 (5) :672-676.
|
|
[13]Thaker PH, Han LY, Kamat AA, et al.Chronic stress pro-motes tumor growth and angiogenesis in a mouse model ofovarian carcinoma[J].Nat Med, 2006, 12 (8) :939-944.
|
|
[14]Ondicova K, Mravec B.Role of nervous system in cancer aetio-pathogenesis[J].Lancet Oncol, 2010, 11 (6) :596-601.
|
|
[15]Xiong W, Ren ZG, Qiu SJ, et al.Residual hepatocellular car-cinoma after oxaliplatin treatment has increased metastaticpotential in a nude mouse model and is attenuated by Songy-ou Yin[J].BMC Cancer, 2010, 10:219.
|
DownLoad: